Beyond the Evidence: Why the Nicotine Sector Needs Credibility, Collaboration and Long-Term Thinking

NewsLeave a comment

The scientific evidence surrounding smoke-free nicotine products is only one part of the challenge facing the nicotine sector. Even where manufacturers believe the evidence supports differentiated approaches to regulation, that evidence does not automatically translate into public understanding, regulatory acceptance or proportionate policy. That disconnect was at the centre of the GINN panel “We’re Right…

Evidence Is Not Enough: Why the Nicotine Sector Must Strengthen Its Case

NewsLeave a comment

Reporting contributed by Kiran Sidhu   “For those in the pouch industry, the harm reduction benefit of choosing a non-combustible nicotine product is irrefutably evident,” Joel Rubenstein told the audience. However, he said, step outside and the environment is hostile to this evidence-based fact.    Rubenstein, an independent commercial consultant, was speaking at InterTabac, an…

GINN Response: Nicotine Pouches Are Not “Beyond the Law” in India

News, RegulationsLeave a comment

A recent explainer asks whether nicotine pouches are “beyond the law” in India and concludes by suggesting that the government could quickly prohibit their import and sale on health grounds. The article identifies genuine uncertainty around the treatment of tobacco-free nicotine pouches under India’s existing legislation. However, the suggestion that these products effectively occupy a…

The Pouch Effect: Could Nicotine Pouches Help Close Sweden’s Smoking Gender Gap?

News, ScienceLeave a comment

Sweden’s unusually low smoking prevalence has long attracted international attention. Much of the discussion has focused on the country’s long history of snus use, particularly among men. But Sweden’s nicotine market is changing. Tobacco-free nicotine pouches have grown rapidly, and their uptake among women raises a new question: could a product category with broader appeal…

The Nicotine Pouch Evidence Base Has Changed: What a New 2026 Scoping Review Tells Regulators

News, ScienceLeave a comment

The evidence surrounding oral nicotine pouches has expanded rapidly. Questions that only a few years ago were being considered using a relatively small body of research can now be examined across studies covering product characteristics, nicotine delivery, toxicant exposure, patterns of use, smoking behaviour, marketing and consumer perceptions. For regulators, this expanding evidence base creates…

Can Europe Agree on Risk-Proportionate Nicotine Taxation? What the EU Tax Debate Reveals

News, RegulationsLeave a comment

Europe’s nicotine market has changed considerably since the EU’s tobacco excise framework was last substantially updated. Cigarettes remain the dominant source of tobacco-related harm, but heated tobacco products, e-cigarettes and nicotine pouches now form part of a much more diverse market. The European Commission is attempting to respond through its proposed revision of the Tobacco…

Can Digital Search Trends Help Regulators Keep Pace With Changing Nicotine Markets?

News, ScienceLeave a comment

Nicotine markets can change faster than the systems designed to monitor them. New products enter the market, public-health controversies emerge, regulations change and consumers encounter new information online, sometimes long before conventional surveys can provide a clear picture of what is happening. This creates a challenge for regulators trying to develop policies based on current…

Nicotine Pouches: Harm Reduction or Initiation Pathway? Why the Evidence Points to Different Outcomes for Different Users

News, ScienceLeave a comment

Nicotine pouches are increasingly caught between two competing public-health narratives. One presents them as smoke-free alternatives that could reduce harm among adults who would otherwise continue smoking. The other focuses on their potential to introduce nicotine to young people and people who have never used nicotine. A new pharmacy-focused review accepted by the Journal of…